ATE464066T1 - Neisseria meningitidis igtb los als adjuvans - Google Patents

Neisseria meningitidis igtb los als adjuvans

Info

Publication number: ATE464066T1
Authority: AT; Austria
Prior art keywords: los; adjuvant; igtb; neisseria meningitidis; tri
Prior art date: 2004-05-11

Application number

AT05745670T

Other languages

English (en)

Inventor

Liana Steeghs

De Winkel Johannes Van

Der Ley Peter Van

Original Assignee

Staat Der Nederlanden Vert Doo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-11

Filing date

2005-05-11

Publication date

2010-04-15

2005-05-11 Application filed by Staat Der Nederlanden Vert Doo filed Critical Staat Der Nederlanden Vert Doo

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE464066T1 publication Critical patent/ATE464066T1/de

Links

239000002671 adjuvant Substances 0.000 title abstract 2
241000588650 Neisseria meningitidis Species 0.000 title 1
241001212279 Neisseriales Species 0.000 abstract 2
150000004043 trisaccharides Chemical class 0.000 abstract 2
108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 abstract 1
210000004443 dendritic cell Anatomy 0.000 abstract 1
230000003308 immunostimulating effect Effects 0.000 abstract 1
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical group O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 abstract 1
150000002482 oligosaccharides Polymers 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Diaphragms For Electromechanical Transducers (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Amplifiers (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Fats And Perfumes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Soft Magnetic Materials (AREA)
Steroid Compounds (AREA)

AT05745670T 2004-05-11 2005-05-11 Neisseria meningitidis igtb los als adjuvans ATE464066T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04076401		2004-05-11
PCT/NL2005/000358 WO2005107798A1 (en)	2004-05-11	2005-05-11	NEISSERIA MENINGITIDIS IgtB LOS AS ADJUVANT

Publications (1)

Publication Number	Publication Date
ATE464066T1 true ATE464066T1 (de)	2010-04-15

Family

ID=34928212

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05745670T ATE464066T1 (de)	2004-05-11	2005-05-11	Neisseria meningitidis igtb los als adjuvans

Country Status (18)

Country	Link
US (1)	US20080138359A1 (de)
EP (1)	EP1748791B1 (de)
JP (1)	JP5174457B2 (de)
KR (1)	KR101270838B1 (de)
CN (1)	CN1997392B (de)
AT (1)	ATE464066T1 (de)
AU (1)	AU2005239963B2 (de)
BR (1)	BRPI0511026C1 (de)
CA (1)	CA2566409C (de)
DE (1)	DE602005020608D1 (de)
DK (1)	DK1748791T3 (de)
ES (1)	ES2344114T3 (de)
MX (1)	MXPA06013093A (de)
NZ (1)	NZ551250A (de)
PL (1)	PL1748791T3 (de)
PT (1)	PT1748791E (de)
SI (1)	SI1748791T1 (de)
WO (1)	WO2005107798A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9904581D0 (sv) *	1999-12-15	1999-12-15	A & Science Invest Ab	A novel helicobacter pylori-binding substance and use thereof
KR101515078B1 (ko)	2005-12-22	2015-04-24	글락소스미스클라인 바이오로지칼즈 에스.에이.	백신
GB0607088D0 (en)	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
EP2476433A1 (de)	2006-03-30	2012-07-18	GlaxoSmithKline Biologicals S.A.	Immunogene Zusammensetzung
CA2690708A1 (en)	2007-06-26	2008-12-31	Glaxosmithkline Biologicals S.A.	Vaccine
WO2009049013A2 (en) *	2007-10-09	2009-04-16	Tufts University	Cholera vaccines
UA99659C2 (uk) *	2008-05-30	2012-09-10	Дзе Ю.Ес.Ей., Ес Репрезентед Бай Дзе Секретарі Оф Дзе Армі, Он Бехаф Оф Уолтер Рід Армі	Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
WO2010130899A1 (fr) *	2009-05-14	2010-11-18	Sanofi Pasteur	Vaccin meningocoque a base de lipooligosaccharide (los) et de proteine de neisseria meningitidis
CA2761924C (fr)	2009-05-14	2017-10-31	Sanofi Pasteur	Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
GB0913681D0 (en)	2009-08-05	2009-09-16	Glaxosmithkline Biolog Sa	Immunogenic composition
GB0913680D0 (en)	2009-08-05	2009-09-16	Glaxosmithkline Biolog Sa	Immunogenic composition
GB201003924D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Immunogenic composition
GB201003920D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Method of treatment
MX2012011189A (es)	2010-03-26	2013-02-07	Glaxosmithkline Biolog Sa	Vacuna contra el virus e inmunodeficiencia humana.
JP2014501225A (ja)	2010-09-27	2014-01-20	グラクソスミスクラインバイオロジカルズソシエテアノニム	ワクチン
KR20120068647A (ko) *	2010-12-18	2012-06-27	아이진 주식회사	개선된 면역반응을 유도하는 백신
JP6002763B2 (ja)	2011-07-07	2016-10-05	デスタートデルネダーランデン、フェルト．ドールデミニスターファンフェーウェーエス	グラム陰性細菌の外膜小胞を、洗浄剤を含まずに生産するためのプロセス
GB201310008D0 (en)	2013-06-05	2013-07-17	Glaxosmithkline Biolog Sa	Immunogenic composition for use in therapy
AU2015359503B2 (en)	2014-12-10	2019-05-09	Glaxosmithkline Biologicals Sa	Method of treatment
KR102002034B1 (ko)	2015-07-09	2019-07-22	에스에프씨주식회사	고효율과 장수명을 갖는 유기 발광 소자
US11292808B2 (en) *	2016-01-28	2022-04-05	Intravacc B.V.	Modified hexa-acylated neisserial LPS
EP3263695A1 (de)	2016-06-29	2018-01-03	GlaxoSmithKline Biologicals SA	Immunogene zusammensetzungen
US10918709B2 (en) *	2016-10-31	2021-02-16	Eyegene Inc.	Immune modulator and vaccine composition containing the same
US10973908B1 (en)	2020-05-14	2021-04-13	David Gordon Bermudes	Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en)	2020-07-22	2026-01-27	David Gordon Bermudes	Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL9101359A (nl)	1991-08-07	1993-03-01	Nederlanden Staat	Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat.
AU762369B2 (en) *	1998-11-03	2003-06-26	De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur	LPS with reduced toxicity from genetically modified gram negative bacteria
GB0103170D0 (en) *	2001-02-08	2001-03-28	Smithkline Beecham Biolog	Vaccine composition
WO2003018054A1 (en) *	2001-08-31	2003-03-06	Chiron Srl.	Helicobacter pylori vaccination
US20060057160A1 (en)	2002-08-02	2006-03-16	Ralph Biemans	Vaccine composition
CA2654706A1 (en) *	2006-06-12	2007-12-21	Nathalie Devos	Neisseria meningitidis lipooligosaccharide vaccine

2005
- 2005-05-11 PL PL05745670T patent/PL1748791T3/pl unknown
- 2005-05-11 NZ NZ551250A patent/NZ551250A/en not_active IP Right Cessation
- 2005-05-11 WO PCT/NL2005/000358 patent/WO2005107798A1/en not_active Ceased
- 2005-05-11 PT PT05745670T patent/PT1748791E/pt unknown
- 2005-05-11 DE DE602005020608T patent/DE602005020608D1/de not_active Expired - Lifetime
- 2005-05-11 AU AU2005239963A patent/AU2005239963B2/en not_active Ceased
- 2005-05-11 MX MXPA06013093A patent/MXPA06013093A/es active IP Right Grant
- 2005-05-11 US US11/596,319 patent/US20080138359A1/en not_active Abandoned
- 2005-05-11 SI SI200531025T patent/SI1748791T1/sl unknown
- 2005-05-11 BR BRPI0511026A patent/BRPI0511026C1/pt not_active IP Right Cessation
- 2005-05-11 CA CA2566409A patent/CA2566409C/en not_active Expired - Fee Related
- 2005-05-11 AT AT05745670T patent/ATE464066T1/de active
- 2005-05-11 ES ES05745670T patent/ES2344114T3/es not_active Expired - Lifetime
- 2005-05-11 KR KR1020067026018A patent/KR101270838B1/ko not_active Expired - Fee Related
- 2005-05-11 CN CN2005800181701A patent/CN1997392B/zh not_active Expired - Fee Related
- 2005-05-11 EP EP05745670A patent/EP1748791B1/de not_active Expired - Lifetime
- 2005-05-11 JP JP2007513087A patent/JP5174457B2/ja not_active Expired - Fee Related
- 2005-05-11 DK DK05745670.9T patent/DK1748791T3/da active

Also Published As

Publication number	Publication date
BRPI0511026B1 (pt)	2019-01-08
EP1748791A1 (de)	2007-02-07
SI1748791T1 (sl)	2010-07-30
AU2005239963A1 (en)	2005-11-17
CA2566409A1 (en)	2005-11-17
CA2566409C (en)	2012-12-04
BRPI0511026B8 (pt)	2020-01-21
EP1748791B1 (de)	2010-04-14
ES2344114T3 (es)	2010-08-18
BRPI0511026C1 (pt)	2021-05-25
KR20070029742A (ko)	2007-03-14
DE602005020608D1 (de)	2010-05-27
US20080138359A1 (en)	2008-06-12
NZ551250A (en)	2010-03-26
PT1748791E (pt)	2010-07-15
BRPI0511026A (pt)	2007-11-27
JP2007537248A (ja)	2007-12-20
MXPA06013093A (es)	2007-08-08
DK1748791T3 (da)	2010-06-28
JP5174457B2 (ja)	2013-04-03
WO2005107798A1 (en)	2005-11-17
AU2005239963B2 (en)	2011-01-06
CN1997392B (zh)	2011-06-01
CN1997392A (zh)	2007-07-11
PL1748791T3 (pl)	2010-08-31
KR101270838B1 (ko)	2013-07-04

Legal Events

Date

Code

Title

Description

2010-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1748791

Country of ref document: EP

Publication	Publication Date	Title
ATE464066T1 (de)	2010-04-15	Neisseria meningitidis igtb los als adjuvans
MX393384B (es)	2025-03-24	Adyuvantes sinteticos de glucopiranosil-lipido.
BRPI0409133A (pt)	2006-05-02	formulações farmacêuticas contendo metilnaltrexona
WO2006012209A3 (en)	2007-03-22	A new adjuvant composition
BR0015961A (pt)	2003-06-10	Antìgeno de neisseria de 85kda
CY1109582T1 (el)	2014-08-13	Συνδυασμενα μηνιγγοκοκκινα συζευγματα με κοινη πρωτεϊνη φορεα
UA95237C2 (uk)	2011-07-25	Імуногенна композиція
AU2457100A (en)	2000-09-14	Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
SG170127A1 (en)	2011-04-29	Vaccine compositions comprising a saponin adjuvant
MX2010012999A (es)	2012-03-07	Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
DK2353608T3 (da)	2020-02-10	Polypeptid-vacciner til bred beskyttelse mod hypervirulente meningokok-linjer
DE60303961D1 (de)	2006-05-04	Modifizierte saccharide, deren konjugate sowie deren herstellung
NO20031646L (no)	2003-06-14	Adjuvanssammensetning omfattende et immunostimulatorisk oligonukleotid og en tokol
NO20064781L (no)	2006-12-19	Fremgangsmater og adjuvanser for a forbedre immunresponser mot vaksiner og fremgangsmater for anvendelse
PT1506185E (pt)	2006-10-31	Compostos novos e sua utilizacao
BR0314058A (pt)	2005-07-05	Composições para cuidados pessoais a base de álcool ramificado
NO20034504D0 (no)	2003-10-08	Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet
BRPI0820960B8 (pt)	2021-05-25	composição, composição farmacêutica, e uso da composição
BRPI0409183A (pt)	2006-04-11	policarbonatos e copolicarbonatos altamente ramificados com fluidez aperfeiçoada, sua preparação e aplicação
EA200701172A1 (ru)	2007-10-26	2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
BRPI0412239A (pt)	2006-09-12	sistemas emulsificantes contendo derivados de azetidina
WO2004101737A3 (en)	2005-09-29	A novel adjuvant capable of specifically activating the adaptive immune response
DK1626726T3 (da)	2006-12-27	Anvendelse af lornoxicam eller lornoxicam-analoger
WO2006052602A3 (en)	2006-07-27	Cosmetic agents and methods for the preparation thereof
CL2004000951A1 (es)	2005-03-04	Compuestos de imidazopiridinas, su procedimiento de preparacion y su uso para preparar imidazopiridincetooxinas.